| Cardiogenic shock from left ventricular dysfunction complicating an acute ST-elevation myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 19742431 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cardiogenic shock from left ventricular dysfunction complicating an acute ST-elevation myocardial infarction is associated with high mortality. Much of the current understanding of the importance of emergency revascularization comes from the SHOCK trial. Mortality benefits combined with improved quality of life among the survivors justify the routine use of emergency revascularization in patients <75 years of age and in selected patients >or=75 years of age. This article discusses the SHOCK trial and potential mechanisms of benefit from revascularization as well as more recent information. Adjunctive therapies have been disappointing. To further improve outcomes, earlier pre-emptive and preventive strategies to ensure early revascularization should be pursued. |
| | |
Authors:
|
Cheuk-Kit Wong; Harvey D White |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The American heart hospital journal Volume: 7 ISSN: 1751-7168 ISO Abbreviation: Am Heart Hosp J Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-09-10 Completed Date: 2010-01-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101156064 Medline TA: Am Heart Hosp J Country: England |
Other Details:
|
Languages: eng Pagination: 33-8 Citation Subset: IM |
Affiliation:
|
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty Coronary Artery Bypass Hospital Mortality Humans Myocardial Infarction / complications*, mortality, physiopathology, therapy* Outcome and Process Assessment (Health Care) Quality of Life Randomized Controlled Trials as Topic Shock, Cardiogenic / etiology*, mortality, physiopathology, therapy* Survival Rate United States Ventricular Dysfunction, Left / complications*, mortality, physiopathology, therapy* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: In vitro inhibition of platelet aggregation in response to increasing concentrations of tirofiban in...
Next Document: Non-invasive risk stratification for implantable cardioverter-defibrillator placement--heart rate va...